(Q53955104)
Statements
A randomised, double-blind comparison of the angiotensin II receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of mild-to-moderate hypertension. (English)
A Mimran
L Ruilope
L Kerwin
M Nys
D Owens
K Kassler-Taub
M Osbakken
1 March 1998
12
3
203-208